Skip to content
Fiscal Receipts

Senate LDA lobbying filing

Pfizer Inc.

A public disclosure record: who filed, what they reported, and the program connections found in the text.
Registrant: Pfizer Inc. Year: 2025 Period: Second Quarter Type: 2A

Filed as: PFIZER INC.. Search lda.senate.gov for that string; the name above is this site’s casing of it, nothing else.

View on lda.senate.gov ↗

Reported income

not reported

Reported expenses

$3.71M

Connections in the record

Tracked program mentions1

Lobbying activities5

  • Budget/AppropriationsBUD

    HR 1 - One Big Beautiful Bill Act CDC Reform Vaccine Policy Reconciliation Research & Development

  • Health IssuesHCR

    S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 832 - EPIC Act of 2025 HR 1 - One Big Beautiful Bill Act CDC Reform Vaccine Policy Reconciliation Research & Development HR 946 - ORPHAN Cures Act HR 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program HR 2214 - DRUG Act HR 2450 - Prescription Drug Transparency and Affordability Act PL 117-328 Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Biosimilars Access, Reimbursement and Reform 340B Reform Prescription Drug User Fee Act (PDUFA) Inflation Reduction Act (IRA) Pill Penalty Vaccine Coverage and Access Intellectual Property Protections PBM Reform Cancer Policies Drug Pricing

  • Medicare/MedicaidMMM

    S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 832 - EPIC Act of 2025 HR 946 - ORPHAN Cures Act HR 2450 - Prescription Drug Transparency and Affordability Act Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform Medicaid Prescription Drug Access Digital Therapeutics

  • Taxation/Internal Revenue CodeTAX

    VICP Reform and Excise Tax Vaccine Injury Compensation Program

  • Trade (domestic/foreign)TRD

    International Supply Chain Global Access Tariffs Non-Tariff Trade Barriers

Lobbyists9

  • ANGELA WILES
  • CATHERINE ROBINSON
  • ELISSA ALBEN
  • EMILY MUELLER
  • FRANCISCO CARRILLO
  • JENNIFER WALTON
  • MATTHEW STROIA
  • PAULA BURG
  • STEPHEN CLAEYS

Source: U.S. Senate Lobbying Disclosure Act database. Underlined dollar figures cite the filing record on lda.senate.gov and open to that citation. Amounts shown as “not reported” are absent from the filing itself.